Self- versus conventional management of oral anticoagulant therapy: Effects on INR variability and coumarin dose in a randomized controlled trial

American Journal of Cardiovascular Drugs

Volumn 7, Issue 3, 2007, Pages 191-197

  Christensen, Thomas Decker ^a   Maegaard, Marianne ^a   Sørensen, Henrik Toft ^a   Hjortdal, Vibeke Elisabeth ^a   Hasenkam, J Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN; PHENPROCOUMON; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; EDUCATION PROGRAM; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF CARE; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANTICOAGULANTS; DRUG MONITORING; FEMALE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PATIENT EDUCATION; PHENPROCOUMON; SELF ADMINISTRATION; THROMBOEMBOLISM; TREATMENT OUTCOME; WARFARIN;

EID: 34447252793     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200707030-00005     Document Type: Article

References (21)

1. Hirsh J, Dalen J, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001; 119 Suppl. 1: 8S-21S
2. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA 1999; 281 (2): 145-50
3. Cromheecke ME, Levi M, Colly LP, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000; 356 (9224): 97-102
4. Körtke H, Körfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 2001; 72 (1): 44-8
5. Horstkotte D, Piper C, Schulte HD, et al. Improvement of prognosis by home prothrombin estimation in patients with life-long anticoagulant therapy [abstract]. Eur Heart J 1996; 17: 230
6. Fitzmaurice DA, Murray ET, Gee KM, et al. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. J Clin Pathol 2002; 55 (11): 845-9
7. Sidhu P, O'Kane HO. Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Ann Thorac Surg 2001; 72 (5): 1523-7
8. Gadisseur AP, Breukink-Engbers WG, van der Meer FJ, et al. Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Arch Intern Med 2003; 163 (21): 2639-46
9. Menendez-Jandula B, Souto JC, Oliver A, et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Ann Intern Med 2005; 142 (1): 1-10
10. Sunderji R, Gin K, Shalansky K, et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Can J Cardiol 2004; 20 (11): 1117-23
11. Fitzmaurice DA, Murray ET, McCahon D, et al. Self management of oral anticoagulation: randomised trial. BMJ 2005; 331 (7524): 1057
12. Christensen TD, Maegaard M, Sørensen HT, et al. Self-management versus conventional management of oral anticoagulant therapy: a randomized, controlled trial. Eur J Intern Med 2006; 17 (4): 260-6
13. Völler H, Glatz J, Taborski U, et al. Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Z Kardiol 2005; 94 (3): 182-6
14. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367 (9508): 404-11
15. Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995; 333 (1): 11-7
16. Christensen TD. Self-management of oral anticoagulant therapy: a review. J Thromb Thrombolysis 2004; 18 (2): 127-43
17. Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation: a multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med 1993; 118 (7): 511-20
18. Butchart EG, Payne N, Li HH, et al. Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg 2002; 123 (4): 715-23
19. Poli D, Antonucci E, Gensini GF, et al. Asymptomatic excessive coumarin anticoagulation is a risk factor for thrombotic and bleeding complications of oral anticoagulant therapy. J Thromb Haemost 2003; 1 (8): 1840-1
20. McGlasson DL. A review of variables affecting PTs/INRs. Clin Lab Sci 1999; 12 (6): 353-8
21. Awad MA, Selim TE, Al-Sabbagh FA. Influence of storage time and temperature on international normalized ratio (INR) levels and plasma activities of vitamin K dependent clotting factors. Hematology 2004; 9 (5-6): 333-7